Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-17-004954
Filing Date
2017-01-20
Accepted
2017-01-20 17:28:37
Documents
1
Period of Report
2016-11-22

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 3517
  Complete submission text file 0001209191-17-004954.txt   4990
Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Issuer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CORBUS PHARMACEUTICALS HOLDINGS, INC 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address
Cohen Yuval (Reporting) CIK: 0001626003 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37348 | Film No.: 17539351